{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:06:15Z","timestamp":1776769575480,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Int"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13340-022-00593-y","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T11:04:56Z","timestamp":1658487896000},"page":"698-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c"],"prefix":"10.1007","volume":"13","author":[{"given":"Shunsuke","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Otaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Kusumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Morii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5302-9793","authenticated-orcid":false,"given":"Hironori","family":"Waki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"593_CR1","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","volume":"27","author":"DE Goldstein","year":"2004","unstructured":"Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes Care. 2004;27:1761\u201373.","journal-title":"Diabetes Care"},{"key":"593_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM197608192950804","volume":"295","author":"RJ Koenig","year":"1976","unstructured":"Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 1976;295:417\u201320.","journal-title":"N Engl J Med"},{"key":"593_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/clinchem\/47.2.153","volume":"47","author":"L Bry","year":"2001","unstructured":"Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153\u201363.","journal-title":"Clin Chem"},{"key":"593_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/2277-9175.139192","volume":"3","author":"A Karami","year":"2014","unstructured":"Karami A, Baradaran A. Comparative evaluation of three different methods for HbA1c measurement with high-performance liquid chromatography in diabetic patients. Adv Biomed Res. 2014;3:94.","journal-title":"Adv Biomed Res"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ajcp\/104.1.89","volume":"104","author":"A Hamwi","year":"1995","unstructured":"Hamwi A, Schweiger CR, Veitl M, Schmid R. Quantitative measurement of HbA1c by an immunoturbidimetric assay compared to a standard HPLC method. Am J Clin Pathol. 1995;104:89\u201395.","journal-title":"Am J Clin Pathol"},{"key":"593_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2337\/diab.30.7.613","volume":"30","author":"HF Bunn","year":"1981","unstructured":"Bunn HF. Evaluation of glycosylated hemoglobin diabetic patients. Diabetes. 1981;30:613\u20137.","journal-title":"Diabetes"},{"key":"593_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/clinchem\/30.6.1111","volume":"30","author":"WG John","year":"1984","unstructured":"John WG. Effect of Schiff base (labile fraction) on the measurement of glycated hemoglobin by affinity chromatography. Clin Chem. 1984;30:1111\u20132.","journal-title":"Clin Chem"},{"key":"593_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jdi.12024","volume":"3","author":"A Imagawa","year":"2012","unstructured":"Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H, et al. Report of the committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig. 2012;3:536\u20139.","journal-title":"J Diabetes Investig"},{"key":"593_CR9","doi-asserted-by":"publisher","first-page":"em00732","DOI":"10.5799\/jcei\/6340","volume":"11","author":"R Goyal","year":"2019","unstructured":"Goyal R, Sardana V. Labile hemoglobin\u2014a biochemical entity. J Clin Exp Investig. 2019;11:em00732.","journal-title":"J Clin Exp Investig"},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/diacare.8.4.375","volume":"8","author":"R Kawahara","year":"1985","unstructured":"Kawahara R, Amemiya T, Komori T, Hirata Y. The effect of blood glucose concentration on labile A1c in diabetic patients. Diabetes Care. 1985;8:375\u20139.","journal-title":"Diabetes Care"},{"key":"593_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/jclinpath-2014-202346","volume":"67","author":"TP Loh","year":"2014","unstructured":"Loh TP, Peng WK, Chen L, Sethi SK. Application of smoothed continuous labile haemoglobin A1c reference intervals for identification of potentially spurious HbA1c results. J Clin Pathol. 2014;67:712\u20136.","journal-title":"J Clin Pathol"},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1515\/cclm-2021-1321","volume":"60","author":"JR Delanghe","year":"2022","unstructured":"Delanghe JR, Lambrecht S, Fiers T, Speeckaert MM. Labile glycated hemoglobin: an underestimated laboratory marker of short term glycemia. Clin Chem Lab Med. 2022;60:451\u20135.","journal-title":"Clin Chem Lab Med"},{"key":"593_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jcla.21705","volume":"28","author":"S Badiou","year":"2014","unstructured":"Badiou S, Guillot J, Kuster N, Bargnoux A, Aguilar-Martinez P, Boissier E, et al. Comparison of Arkray\/ELITech ADAMS HA-8180V\u00ae with Bio-Rad Variant, TMII Turbo2.0\u00ae and Tosoh Bioscience HLC\u00ae-723G8 for HbA1c determination. J Clin Lab Anal. 2014;28:428\u201334.","journal-title":"J Clin Lab Anal"},{"key":"593_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13340-019-00407-8","volume":"11","author":"M Koga","year":"2020","unstructured":"Koga M, Okuda M, Inada S, Ueda S-I, Nakamura Y, Okumiya T, et al. HbA1c levels measured by enzymatic assay during off-site health checkups are lower than those measured by on-site HPLC assay. Diabetol Int. 2020;11:67\u201371.","journal-title":"Diabetol Int"},{"key":"593_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40200-020-00503-6","volume":"19","author":"MT Jalali","year":"2020","unstructured":"Jalali MT, Bavarsad SS, Hesam S, Afsharmanesh MR, Mohammadtaghvaei N. Assessing agreement between the three common clinical measurement methods of HbA1c. J Diabetes Metab Disord. 2020;19:273\u20139.","journal-title":"J Diabetes Metab Disord"},{"key":"593_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s13340-021-00529-y","volume":"13","author":"K Yoshino","year":"2022","unstructured":"Yoshino K, Hirota Y, Ogawa W, Sugawara K, Kawaguchi A, Yoshino H, et al. A case of \u03b1-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay. Diabetol Int. 2022;13:330\u20135.","journal-title":"Diabetol Int"},{"key":"593_CR17","first-page":"387","volume":"46","author":"M Koga","year":"2016","unstructured":"Koga M, Inada S, Miyazaki A. Identification of the presence of variant hemoglobin using a measurement of the Labile HbA1c (#C) fraction. Ann Clin Lab Sci. 2016;46:387\u201392.","journal-title":"Ann Clin Lab Sci"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/clinchem\/39.1.138","volume":"39","author":"CW Weykamp","year":"1993","unstructured":"Weykamp CW, Penders TJ, Siebelder CW, Muskiet FA, van der Slik W. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem. 1993;39:138\u201342.","journal-title":"Clin Chem"},{"key":"593_CR19","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1016\/S0021-9258(19)62688-8","volume":"261","author":"RC San George","year":"1986","unstructured":"San George RC, Hoberman HD. Reaction of acetaldehyde with hemoglobin. J Biol Chem. 1986;261:6811\u201321.","journal-title":"J Biol Chem"},{"key":"593_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJM198104023041406","volume":"304","author":"R Fl\u00fcckiger","year":"1981","unstructured":"Fl\u00fcckiger R, Harmon W, Meier W, Loo S, Gabbay KH. Hemoglobin carbamylation in uremia. N Engl J Med. 1981;304:823\u20137.","journal-title":"N Engl J Med"},{"key":"593_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1172\/JCI110043","volume":"67","author":"VJ Stevens","year":"1981","unstructured":"Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Investig. 1981;67:361\u20139.","journal-title":"J Clin Investig"},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1172\/JCI108068","volume":"56","author":"KR Bridges","year":"1975","unstructured":"Bridges KR, Schmidt GJ, Jensen M, Cerami A, Bunn HF. The acetylation of hemoglobin by aspirin. In vitro and in vivo. J Clin Investig. 1975;56:201\u20137.","journal-title":"J Clin Investig"},{"key":"593_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/193229680900300307","volume":"3","author":"RR Little","year":"2009","unstructured":"Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol. 2009;3:446\u201351.","journal-title":"J Diabetes Sci Technol"},{"key":"593_CR24","unstructured":"Summaries of mutation categories [Internet]. [cited 2022 Jan 3]. https:\/\/globin.bx.psu.edu\/cgi-bin\/hbvar\/counter. Accessed 3 Jan 2022."},{"key":"593_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s13340-011-0045-8","volume":"4","author":"H Ijima","year":"2011","unstructured":"Ijima H, Jinnouchi H, Hamaguchi K, Ohguni S, Haga Y, Nagashima M, et al. Cases with Hb Toranomon show abnormal HbA1c levels measured by upgraded high-performance liquid chromatography models. Diabetol Int. 2011;4:202\u20137.","journal-title":"Diabetol Int"},{"key":"593_CR26","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2169\/internalmedicine.54.4017","volume":"54","author":"K Iizuka","year":"2015","unstructured":"Iizuka K, Mizuno M, Niwa H, Takeda J. A rare case of variant hemoglobin (Hb Yahata) suspected based on inconsistent plasma glucose and HbA1c levels. Intern Med. 2015;54:1771\u20135.","journal-title":"Intern Med"},{"key":"593_CR27","doi-asserted-by":"publisher","first-page":"e22155","DOI":"10.1002\/jcla.22155","volume":"32","author":"E Urrechaga","year":"2018","unstructured":"Urrechaga E. Analytical evaluation of the ADAMSTM A1c HA8180T analyzer for the measurement of HbA1c. J Clin Lab Anal. 2018;32:e22155.","journal-title":"J Clin Lab Anal"}],"container-title":["Diabetology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13340-022-00593-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13340-022-00593-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13340-022-00593-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T02:18:57Z","timestamp":1663294737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13340-022-00593-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s13340-022-00593-y","relation":{},"ISSN":["2190-1678","2190-1686"],"issn-type":[{"value":"2190-1678","type":"print"},{"value":"2190-1686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and\/or with the Helsinki Declaration of 1964 and later versions. Formal ethics approval was waived for this paper by the ethics committee of Akita University Graduate School of Medicine due to its being a case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patients for publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}